A02 - Notice of Intent to Award Sole Source_INTEGRA.doc

NOTICE OF INTENT TO SOLE SOURCE:

This notice announces the intent by the U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to award a firm-fixed priced, sole source, contract to INTEGRA Biosciences Corporation (INTEGRA), 22 Friars Drive, Hudson, NH 03051. INTEGRA is sole manufacturer and retailer of the WELLJET Dispenser. In additional to the WELLJET Dispensers, USAMRIID requires proprietary pipettes, software, accessories, disposables, training, and a preventative maintenance plan for the dispensers. INTEGRA is the sole provider of the WELLJET Dispenser system(s) and proprietary pipettes with the locking tip design.

The North American Industry Classification System (NAICS) for this requirement is 334516 - Analytical Laboratory Instrument Manufacturing.

This announcement fulfills the synopsis requirements under FAR 5.203(a). This Special Notice of Intent is not a request for competitive quotes and no solicitation document exists for this requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the tasks identified within this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement or a sole source procurement is in the best interest of the Government.

All questions and responses concerning this notice shall be emailed to Deborah Hagan via email at deborah.l.hagan.civ@health.mil.

Capability statements are due, in writing, to the email address listed above no later than 10:00 AM EST, 15 September 2023. Capability statements shall be submitted via email ONLY as Microsoft Word or Adobe PDF attachment. No phone calls will be accepted.